NY - Senator George D. Maziarz (R-62) and Assembly Member Daniel J. Burling (R-147) introduced the “New York State Pharmaceutical Drug Manufacturer and Wholesaler Disclosure Act” (S.B. 212, A.B. 5978).
The Act would require, “Any pharmaceutical drug manufacturer or pharmaceutical drug wholesaler, including any employee or agent of such manufacturer or wholesaler, that makes any gift [worth $75 or more] whether in the form of money, service, loan, travel, entertainment, hospitality, thing or promise, or in any other form, to a health care provider” shall file an annual report of “all gifts made by the manufacturer or wholesaler to health care providers”. The annual report would include “an itemized list containing a description of each gift… and the name, address and telephone number of the health care provider who received each gift”, as well as its value. S.B. 212 defines “health care provider” as “any physician or other person who is legally authorized to prescribe drugs”.
Given that “gifts” could include incentives for health care providers participating in marketing research studies, MRA will seek to amend or defeat S.B. 212 and A.B. 5978.